Instant Access to the Journals You Need

for just $40 per month.

Get 2 Weeks Free

OROS Methylphenidate-Induced Skin Eruptions

OROS Methylphenidate-Induced Skin Eruptions


Letter to the Editor OROS Methylphenidate-Induced Skin Eruptions Murat Coskun, M.D., Mustafa Deniz Tutkunkardas, M.D., and Salih Zoroglu, M.D. ethylphenidate (MPH) has rarely been reported to cause skin eruptions (SE) in subjects with attentiondeficit=hyperactivity disorder (ADHD) (Cohen et al. 1992; Confino and Goldberg 2005). Here we report the case of an 8-year-old boy with ADHD who developed maculopapular pruritic SE with OROS MPH (Concerta) but not with immediate release (IR) MPH (Ritalin) treatment. Case Report The subject is an 8-year-old boy who presented with his mother due to typical symptoms of ADHD. He was given a diagnosis of ADHD combined type with normal intellectual capacity. His prenatal, postnatal, and early developmental history was unremarkable. He had a generalized tonic–clonic seizure at 3 years of age, but has been seizure free since then. He had been on valproate 150– 250 mg=day treatment between 3 and 4 years of age. However because his control electroencephalogram (EEG) revealed abnormality, he was restarted with valproate 400 mg=day for the last 3 months. He has no known drug or food allergies so far. He has never been treated with any psychopharmacological agent except for the previous and current antiepileptic treatments. No dermatologic reactions
Loading next page...

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for only $40/month.

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.

Stop missing out on the latest updates in your field

  • We’ll send you automatic email updates on the keywords and journals you tell us are most important to you.
  • There is a lot of content out there, so we help you sift through it and stay organized.